Aspire-Lakewood vs Vyome
ASBP and HIND side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ASBP and HIND compare
Aspire-Lakewood and Vyome are about the same size, with market caps of $11.8M and $11.1M.
Vyome keeps more of each dollar of sales as profit, with a net margin of −2456% compared with −11314% at Aspire-Lakewood.
Aspire-Lakewood scores higher on the StockData Score (2 against 1 for Vyome), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ASBP | HIND |
|---|---|---|
| Size and price | ||
| Market cap | $11.8M | $11.1M |
| Share price | $8.41 | $1.58 |
| Change, 1 year | 95.9% | −70.3% |
| Change, 5 years | – | −100.0% |
| Beta (5Y) | – | 1.56 |
| Employees | – | 18 |
| StockData Score | ||
| Total score | 2 (better) | 1 |
| Valuation score | 1 (better) | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 121× | 72.4× (better) |
| P/B | 1.0× | – |
| Growth | ||
| Revenue growth (TTM) | – | −55.6% |
| Revenue growth, 5Y average | – | −51.0% |
| Profitability | ||
| Gross margin | −25.0% | 50.4% (better) |
| Operating margin | −7495% | −2854% (better) |
| Net margin | −11314% | −2456% (better) |
| Return on equity | −1032% | −149% (better) |
| Financial health | ||
| Interest coverage | −0.8× (better) | −229.3× |
| Current ratio | 7.99 (better) | 3.68 |
| Altman Z-score | −0.05 (better) | −12.31 |
| Piotroski F-score | 3 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −53.1% |
| Shareholder yield | 0.00% (better) | −53.1% |
| Ownership | ||
| Held by institutions | – | 2.0% |
| Held by insiders | 1.4% | 6.8% |
| Short interest, % of float | – | 0.28% |
Go deeper
- ASBP stock overview
- ASBP income statement
- ASBP valuation and score
- HIND stock overview
- HIND income statement
- HIND valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.